0 Comentários
0 Compartilhamentos
1308 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
- Faça Login para curtir, compartilhar e comentar!
- Understanding Corticosteroid Therapy in Duchenne Muscular Dystrophy (DMD) TreatmentCorticosteroid therapy is a cornerstone of Duchenne Muscular Dystrophy (DMD) treatment. These medications, such as prednisone and deflazacort, have shown significant benefits in slowing disease progression and prolonging ambulation in individuals with DMD. Corticosteroids work by reducing inflammation and suppressing muscle fiber damage, thus preserving muscle strength and function. However,...0 Comentários 0 Compartilhamentos 1731 Visualizações 0 Anterior
- A New Hope for DMD: Sarepta’s ELEVIDYS Gene TherapySarepta’s ELEVIDYS: First Gene Therapy for Duchenne Muscular Dystrophy (DMD) Treatment Duchenne muscular dystrophy (DMD) is a devastating genetic disorder that primarily affects boys, leading to progressive muscle degeneration and weakness. Historically, DMD has been managed through supportive care, steroids, and emerging pharmaceutical therapies, but there has been no cure. The...0 Comentários 0 Compartilhamentos 491 Visualizações 0 Anterior
- Advances in Duchenne Muscular Dystrophy TreatmentCauses and Mechanism of Duchenne Muscular Dystrophy Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. It is caused by the absence of dystrophin, a protein that helps keep muscle cells intact. The defective gene that causes DMD is located on the X chromosome, so it primarily affects boys. Girls can be carriers of the defective...0 Comentários 0 Compartilhamentos 775 Visualizações 0 Anterior
- Breakthroughs in Alzheimer’s Disease Research: What’s on the Horizon?What Does the Future Hold For Gene Therapy in the Duchenne Muscular Dystrophy (DMD) Treatment Market? Duchenne muscular dystrophy (DMD) is a severe, X-linked genetic disorder characterized by progressive muscle degeneration and weakness. Affecting approximately 1 in 3,500 to 5,000 males globally, DMD is caused by mutations in the dystrophin gene, leading to the absence of dystrophin...0 Comentários 0 Compartilhamentos 480 Visualizações 0 Anterior
- NASH: Meeting the Unmet Challenges in Liver HealthNASH: Meeting the Unmet Challenges in Liver Health Meeting the Unmet: Nonalcoholic Steatohepatitis (NASH) Nonalcoholic Steatohepatitis (NASH) is a progressive liver disease that represents a significant unmet medical need. Characterized by inflammation and damage in the liver, NASH is a severe form of nonalcoholic fatty liver disease (NAFLD), and its prevalence has been steadily increasing...0 Comentários 0 Compartilhamentos 430 Visualizações 0 Anterior
- Next-Gen Therapeutic Strategies: Nucleic Acids and Gene Therapies for Neuromuscular DisordersNucleic Acids and Gene Therapies in Neuromuscular Disorders: Next-Generation Therapeutic Strategies Neuromuscular disorders (NMDs) are a diverse group of conditions characterized by the progressive degeneration of muscle and nerve function. Among these, Duchenne muscular dystrophy (DMD) stands out as a devastating condition with no cure, resulting from mutations in the dystrophin gene....0 Comentários 0 Compartilhamentos 410 Visualizações 0 Anterior